Comparative efficacy of three commercial PCV2 vaccines in conventionally reared pigs

Veterinary Journal

Volumn 189, Issue 1, 2011, Pages 58-62

  Lyoo, KwangSoo ^a   Joo, HanSoo ^a   Caldwell, Brian ^b   Kim, HyeunBum ^a   Davies, Peter R ^a   Torrison, Jerry ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Choice Connection   (United States)

Author keywords

Conventional pigs; Efficacy; Porcine circovirus type 2; Vaccine

Indexed keywords

CIRCOFLEX; CIRCUMVENT PCV; PORCINE CIRCOVIRUS TYPE 2 VACCINE; SUVAXYN PCV2; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CIRCOVIRUS; CIRCOVIRUS TYPE 2; CONTROLLED STUDY; DRUG EFFICACY; FLUORESCENT ANTIBODY TECHNIQUE; NONHUMAN; SWINE; VIREMIA; VIRUS NEUTRALIZATION; WEIGHT GAIN;

ANIMALS; ANTIBODIES, VIRAL; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; SWINE; SWINE DISEASES; TIME FACTORS; VACCINATION; VIRAL VACCINES; VIREMIA; WEIGHT GAIN;

PORCINE CIRCOVIRUS 2; SUIDAE;

EID: 79955741820     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.06.015     Document Type: Article

References (26)

1. Blanchard P., Mahe D., Cariolet R., Keranflec'h A., Baudouard M.A., Cordioli P., Albina E., Jestin A. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 2003, 21:4565-4575.
2. Cheung A.K., Lager K.M., Kohutyuk O.I., Vincent A.L., Henry S.C., Baker R.B., Rowland R.R., Dunham A.G. Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Archives of Virology 2007, 152:1035-1044.
3. Dupont K., Nielsen E.O., Baekbo P., Larsen L.E. Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time. Veterinary Microbiology 2008, 128:56-64.
4. Fachinger V., Bischoff R., Jedidia S.B., Saalmuller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26:1488-1499.
5. Fenaux M., Opriessnig T., Halbur P.G., Elvinger F., Meng X.J. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. Journal of Virology 2004, 78:6297-6303.
6. Fort M., Olvera A., Sibila M., Segales J., Mateu E. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Veterinary Microbiology 2007, 125:244-255.
7. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segales J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26:1063-1071.
8. Gagnon C.A., Tremblay D., Tijssen P., Venne M.H., Houde A., Elahi S.M. The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada. Canadian Veterinary Journal 2007, 48:811-819.
9. Hamel A.L., Lin L.L., Nayar G.P. Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. Journal of Virology 1998, 72:5262-5267.
10. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., Hays M., Anderson J., Rowland R.R. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. Journal of American Veterinary Medical Association 2008, 232:906-912.
11. Kixmoller M., Ritzmann M., Eddicks M., Saalmuller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26:3443-3451.
12. Lyoo K.S., Kim H.B., Joo H.S. Evaluation of a nested polymerase chain reaction assay to differentiate between two genotypes of porcine circovirus-2. Journal of Veterinary Diagnostic Investigation 2008, 20:283-288.
13. McKeown N.E., Opriessnig T., Thomas P., Guenette D.K., Elvinger F., Fenaux M., Halbur P.G., Meng X.J. Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2. Clinical and Diagnostic Laboratory Immunology 2005, 12:1347-1351.
14. Meerts P., Van Gucht S., Cox E., Vandebosch A., Nauwynck H.J. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunology 2005, 18:333-341.
15. Olvera A., Cortey M., Segales J. Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virology 2007, 357:175-185.
16. Opriessnig T., Yu S., Thacker E.L., Halbur P.G. Derivation of porcine circovirus type 2-negative pigs from positive breeding herds. Journal of Swine Health Production 2004, 12:186-191.
17. Opriessnig T., Meng X.J., Halbur P.G. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. Journal of Veterinary Diagnostic Investigation 2007, 19:591-615.
18. Opriessnig T., Patterson A.R., Elsener J., Meng X.J., Halbur P.G. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccinations to protect pigs from experimental infection with PCV2. Clinical and Vaccine Immunology 2008, 15:397-401.
19. Opriessnig T., Ramamoorthy S., Madson D.M., Patterson A.R., Pal N., Carman S., Meng X.J., Halbur P.G. Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection. Journal of General Virology 2008, 89:2482-2491.
20. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27:1002-1007.
21. Paul P.S., Mengeling W.L., Pirtle E.C. Duration and biological half-life of passively acquired colostral antibodies to porcine parvovirus. American Journal of Veterinary Research 1982, 43:1376-1379.
22. Ritzmann, M., Kixmoeller, M., 2007. Field efficacy study of a PCV2 vaccine in three week old piglets in Southern Germany. In: Proceedings of 5th International Symposium on Emerging and Re-emerging Pig Diseases, Krakau, Poland, p. 118.
23. Segales J., Allan G.M., Domingo M. Porcine circovirus diseases. Animal Health Research Review 2005, 6:119-142.
24. Thacker, B., Wilson, W., Johnsom, J., Francisco, C., Schlueter, R., 2008. Circumvent PCV vaccine: performance and serology evaluation. In: Proceedings of 20th International Pig Veterinary Society Congress, Durban, South Africa, p. 90.
25. Urniza, A., Segales, J., Balasch, M., Bru, T., Fraile, L., Nofrarias, M., Alegre, A., Lopez-Soria, S., Sibila, M., Xu, Z., Chu, H. J., Plana-Duran, J., 2008. Efficacy of the vaccine Suvaxyn Circo One shot for the prophylaxis of PMWS under field conditions. In: Proceedings of 20th International Pig Veterinary Society Congress, Durban, South Africa, p. 55.
26. Walker I.W., Konoby C.A., Jewhurst V.A., McNair I., McNeilly F., Meehan B.M., Cottrell T.S., Ellis J.A., Allan G.M. Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2. Journal of Veterinary Diagnostic Investigation 2000, 12:400-405.